mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray [Nasonex]
- RxCUI
- 1797870
- RxNorm name
- mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray [Nasonex]
- Display name
- NASONEX (Nasal)
- Full name
- mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray [Nasonex]
- Term type
- SBD
- Status
- Active
- Strength
- 50 mcg/puff
- Dose form
- Metered dose spray
- Route
- Nasal
- Updated
- 2026-10-24 12:29:48
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 072016
- Active start
- 072016
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| mometasone furoate | 0.05 MG / 1 ACTUAT | mometasone | mometasone furoate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Metered Dose Nasal Spray | 1797831 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| mometasone | 108118 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Nasonex 50 MCG/ACTUAT Metered Dose Nasal Spray | 1 | NAMES |
| RxNorm Name | mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray [Nasonex] | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 1797870 | 1 | CODES |
| MMSL_CODE | BD6453 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0113-1720-01 | 0113-1720 | Nasonex mometasone furoate | L. Perrigo Company | NDA215712 |
| 0113-1720-02 | 0113-1720 | Nasonex mometasone furoate | L. Perrigo Company | NDA215712 |
| 0113-1720-04 | 0113-1720 | Nasonex mometasone furoate | L. Perrigo Company | NDA215712 |
| 0113-1720-06 | 0113-1720 | Nasonex mometasone furoate | L. Perrigo Company | NDA215712 |
| 0113-1720-07 | 0113-1720 | Nasonex mometasone furoate | L. Perrigo Company | NDA215712 |
| 0113-1720-11 | 0113-1720 | Nasonex mometasone furoate | L. Perrigo Company | NDA215712 |
| 0113-1999-01 | 0113-1999 | Childrens Nasonex mometasone furoate | L. Perrigo Company | NDA215712 |
| 0113-1999-11 | 0113-1999 | Childrens Nasonex mometasone furoate | L. Perrigo Company | NDA215712 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nasonex | MOMETASONE FUROATE | L. Perrigo Company | 13696a8b-366a-4a5e-adea-d5b7bff9e46f | 2026-08-19 | Warnings | 0113-1720-11 0113-1720-06 0113-1720-04 0113-1720-07 0113-1720-02 0113-1720-01 0113-1720 00113172002 00113172001 00113172011 00113172004 00113172007 00113172003 00113172006 00113172005 1797870 |
| Childrens Nasonex | MOMETASONE FUROATE | L. Perrigo Company | e15d055e-9a25-46b4-8724-3609cf2dc062 | 2024-08-28 | Warnings | 0113-1999-01 0113-1999-11 0113-1999 00113199901 00113199911 1797870 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 13696a8b-366a-4a5e-adea-d5b7bff9e46f | NASONEX 50 MCG/ACTUAT Metered Dose Nasal Spray [PSN] · mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray [Nasonex] [SBD] · Nasonex 0.05 MG/ACTUAT Metered Dose Nasal Spray [SY] · Nasonex 50 MCG/ACTUAT Metered Dose Nasal Spray [SY] | 4 | 7 | Nasonex® 24HR Allergy Drug Facts | 20250819 |
| e15d055e-9a25-46b4-8724-3609cf2dc062 | NASONEX 50 MCG/ACTUAT Metered Dose Nasal Spray [PSN] · mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray [Nasonex] [SBD] · Nasonex 0.05 MG/ACTUAT Metered Dose Nasal Spray [SY] · Nasonex 50 MCG/ACTUAT Metered Dose Nasal Spray [SY] | 4 | 3 | Children’s Nasonex ® 24HR Allergy Drug Facts | 20240828 |
| a06f66a9-ca36-48c6-a00d-4f614b539cdf | NASONEX 50 MCG/ACTUAT Metered Dose Nasal Spray [PSN] · mometasone furoate 0.05 MG/ACTUAT Metered Dose Nasal Spray [Nasonex] [SBD] · Nasonex 0.05 MG/ACTUAT Metered Dose Nasal Spray [SY] · Nasonex 50 MCG/ACTUAT Metered Dose Nasal Spray [SY] | 4 | 1 | These highlights do not include all the information needed to use NASONEX safely and effectively. See full prescribing information for NASONEX. NASONEX ® (mometasone furoate monohydrate) Nasal Spray 50 mcg † † calculated on the anhydrous basis Initial U.S. Approval: 1997 | 20110126 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 13696a8b-366a-4a5e-adea-d5b7bff9e46f | Nasonex® 24HR Allergy Drug Facts | L. Perrigo Company | 20260819 |
| 30507dfb-c5a4-4e27-e063-6294a90aa87e | Nasonex® 24HR Allergy Drug Facts | Sixarp, LLC | 20250919 |
| 13696a8b-366a-4a5e-adea-d5b7bff9e46f | Nasonex® 24HR Allergy Drug Facts | L. Perrigo Company | 20250819 |
| e15d055e-9a25-46b4-8724-3609cf2dc062 | Children’s Nasonex ® 24HR Allergy Drug Facts | L. Perrigo Company | 20240828 |
| 913422a9-9c8a-4cea-ac4a-482d89febf3a | These highlights do not include all the information needed to use NASONEX safely and effectively. See full prescribing information for NASONEX. NASONEX ® (mometasone furoate monohydrate) nasal spray Initial U.S. Approval: 1997 | Organon LLC | 20210601 |
| 12df48a0-fd2e-4e1c-b135-e616a1f31f42 | These highlights do not include all the information needed to use NASONEX safely and effectively. See full prescribing information for NASONEX. NASONEX ® (mometasone furoate monohydrate) nasal spray Initial U.S. Approval: 1997 | Merck Sharp & Dohme Corp. | 20201210 |
| 2499e7a3-aaff-4a7e-ad3e-e9d928353838 | National Council for Prescription Drug Programs | 20120724 | |
| 3f5c2624-27a1-46f7-a3f1-1c980227440a | National Council for Prescription Drug Programs | 20120724 | |
| a06f66a9-ca36-48c6-a00d-4f614b539cdf | These highlights do not include all the information needed to use NASONEX safely and effectively. See full prescribing information for NASONEX. NASONEX ® (mometasone furoate monohydrate) Nasal Spray 50 mcg † † calculated on the anhydrous basis Initial U.S. Approval: 1997 | Physicians Total Care, Inc. | 20110126 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | R01AD | Corticosteroids | ATC1-4 | mometasone | |
| ATC | D07AC | Corticosteroids, potent (group III) | ATC1-4 | mometasone | |
| ATC | D07XC | Corticosteroids, potent, other combinations | ATC1-4 | mometasone | |
| ATC | R03BA | Glucocorticoids | ATC1-4 | mometasone | |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | mometasone |
| FDASPL | N0000175450 | Corticosteroid Hormone Receptor Agonists | MOA | has_moa | mometasone |
| MEDRT | D000068656 | Mometasone Furoate | CHEM | has_ingredient | mometasone |
| MEDRT | D000068656 | Mometasone Furoate | CHEM | has_ingredient | mometasone furoate |
| MEDRT | D003881 | Dermatomycoses | DISEASE | ci_with | mometasone |
| MEDRT | D003881 | Dermatomycoses | DISEASE | ci_with | mometasone furoate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | mometasone furoate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | mometasone |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | mometasone furoate |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | mometasone |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | mometasone |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | mometasone furoate |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | mometasone |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | mometasone furoate |
| MEDRT | D006561 | Herpes Simplex | DISEASE | ci_with | mometasone furoate |
| MEDRT | D006561 | Herpes Simplex | DISEASE | ci_with | mometasone |
| MEDRT | D006562 | Herpes Zoster | DISEASE | ci_with | mometasone furoate |
| MEDRT | D006562 | Herpes Zoster | DISEASE | ci_with | mometasone |
| MEDRT | D006967 | Hypersensitivity | DISEASE | ci_with | mometasone furoate |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | mometasone furoate |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | mometasone |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | mometasone furoate |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | mometasone |
| MEDRT | D011537 | Pruritus | DISEASE | may_treat | mometasone furoate |
| MEDRT | D011537 | Pruritus | DISEASE | may_treat | mometasone |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | mometasone |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | mometasone furoate |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | mometasone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | mometasone furoate |
| MEDRT | D014382 | Tuberculosis, Cutaneous | DISEASE | ci_with | mometasone |
| MEDRT | D014382 | Tuberculosis, Cutaneous | DISEASE | ci_with | mometasone furoate |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | mometasone |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | mometasone furoate |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | mometasone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | mometasone furoate |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | mometasone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | mometasone furoate |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | mometasone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | mometasone furoate |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | mometasone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | mometasone furoate |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | mometasone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | mometasone furoate |
| MEDRT | N0000009908 | Vasoconstriction | PE | has_pe | mometasone |
| MEDRT | N0000009908 | Vasoconstriction | PE | has_pe | mometasone furoate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.05 MG/ACTUAT (expressed as mometasone furoate) |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA215712 |
| NAMES | Prescribable Synonym | NASONEX 50 MCG/ACTUAT Metered Dose Nasal Spray |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |